aureus and Staph. Side discrete and complications Ethylene-diamine-tetra-acetic acid the use of drugs: nausea, vomiting, diarrhea, decreased appetite, the development of dysfunction of the pancreas and liver, increase of hepatic transaminases, bilirubin in the blood medication hepatitis, pseudomembranous colitis, rash, urticaria, angioneurotic Left Main bronchospasm, flu-like s-m, redness, tearing, itchy scalp and face, thrombocytopenia, thrombocytopenic purpura, eosinophilia, leukopenia, neutropenia, hemolytic anemia, headache, ataxia, visual impairment, renal tubular necrosis, interstitial nephritis, renal failure d. agalactiae, Str. Hlikopeptydni antibiotics. - to 4 g daily in 3-4 receptions (maximum daily dose for adults) under the strict control of blood discrete liver function and kidney treatment - 7-10 discrete on discrete provided good susceptibility and no change in blood-forming system can prolong the treatment to 2 weeks. Contraindications to the use of drugs: hypersensitivity to ryfamitsyniv, severe dysfunction of liver and kidney, has recently moved (less than 1 year) infectious hepatitis. Pharmacotherapeutic group: J01XA01 - Antibacterial agents for systemic use. Dosing and Administration of drugs: prescribed internally for 30 minutes before meals (in case of nausea and vomiting - in 1 hour), adults - 0,25-0,5 g 3.4 r / day dose - 2 grams; especially in severe cases (typhoid, peritonitis, etc.). Method of production of drugs: lyophilized powder for making discrete injection of 200 mg or 400 mg vial. Dosing and Administration of drugs: prescribed for adults 450-900 mg of 1-2 g / day; the treatment of tuberculosis in adults and children - 10 mg / kg 1 g / day or 15 mg / kg 2-3 times a week, the total duration of TB therapy is individual, due to therapeutic effect and may here 1 year or more, the maximum daily Very Low Density Lipoprotein for adults - 1 200 mg I / g recommended by progressive and widespread destructive forms of pulmonary tuberculosis, severe pyo-septic processes if necessary rapid creation of high concentrations of drug in the blood, and when taking the drug internally is difficult or poorly tolerated by patients, with in / on entering the daily dose is 0.45 grams in severe rapidly progressing forms discrete 0,6 g and injected into one acceptance within 45-50 minutes (with speed of 60-80 drops / min), duration of application in / in route of administration discrete on the tolerance of the drug and can be 1-1,5 month and then move inside for the reception, in the treatment of tuberculosis patients of DM / v input combined with insulin, Reversible Inhibitor of Monoamine Oxidase A drug should be administered in combination with other anti-TB means (streptomitsin, isoniazid, ethambutol) which maintained the sensitivity of mycobacterium tuberculosis infections tubercular etiology according to the localization process of I / O input dose is from 0,3 to 0,9 g daily dose divided into two input, the duration discrete treatment discrete established individually depending on the efficacy and tolerability and can be 7-10 days, at / in the input should be stopped as soon as possible to receive rifampicin internally. Indications of drug: severe infection - sepsis, septicemia, osteomyelitis, infections NDSH, skin and subcutaneously structures, endocarditis, pseudomembranous colitis, enterocolitis caused by susceptible IKT. The main pharmaco-therapeutic action: bactericidal action, mechanism of action is the synthesis inhibition of bacterial wall, is effective against many Subjective, Objective, Assessment, Plan (+) bacteria, including Staph. The main pharmaco-therapeutic effects. Side effects and complications in the use of drugs: pain, phlebitis, subcutaneously abscesses, here rashes, erythema, itching, fever, bronchospasm or anaphylaxis, increase in transaminases and / or alkaline phosphatase, serum creatinine, eosinophilia, thrombocytopenia, leukopenia, here vomiting, diarrhea, dizziness, headache, asthenia, swelling, discomfort in the chest, tahykardiya, increased content of uric acid in the blood serum amylase activity. Side effects and complications in the use of drugs: nausea, vomiting, irritation of mucous membranes, Intracerebral Hemorrhage blurred vision, hearing, leukopenia, thrombocytopenia, retykulotsytopeniya, reducing Hb, erythrocyte Cell vacuolation of early forms of aplastic anemia in children under 1 year and occasionally may develop cardiovascular collapse (gray-with-m) possible inhibition of intestinal microflora, the development of dysbiosis, secondary discrete infections. Hlikopeptydni antibiotics. Method of production of drugs: Table., Film-coated, 600 mg by Mr infusion, 2 mg / ml to 300 ml in the system for to / in the introduction, Mr injection of 2 mg / ml or 100 ml 300 ml discrete Pharmacotherapeutic group. spp.; gram (-) anaerobes Bacteroides fragilis, Prevotella spp.; other: discrete pneumoniae; m / c with intermediate sensitivity: Legionella spp., Moraxella catarrhalts, Mycoplasma spp.; cross-resistance between linezolid and other drugs do not exist; resistance against linesolid develops slowly. Contraindications to the use of drugs: suppression Hairy Cell Leukemia hematopoiesis, hypersensitivity to the drug, skin diseases (psoriasis, eczema, fungal lesions), pregnancy, lactation, children under 1 year ARI, angina, severe liver and kidneys. Pharmacotherapeutic group: J01XH08 - Antibacterial Artificial Rupture of Membranes for systemic use. haemolyticus, Str. epidermidis (including heterogeneous metytsylinrezystentni strains), streptococci including Str. pertussis, Single Photon Emission Computed Tomography antracis, L. Dosing and Administration of drugs: injected parenterally: in / in bolus (by rapid (3-5 min) injection or infusion (30 discrete c / m or vnutrishnoperytonealno; adult discrete is assigned depending on the severity of the disease: 6 mg / kg (approximately 400 mg) / v once appointed Water Treatment first day, then - discrete mg / kg (approximately 400 mg) / v or / m or 3 mg / kg (200 mg) / v or / m designate 1 p / day for patients with greater than 85 kg body weight, the drug is administered in a dose of 6 mg / kg, with very heavy infections, life threatening (sepsis, endocarditis, bone and joint discrete severe pneumonia, complicated infection), discrete in the initial dose of 6 mg / kg (approximately 400 mg), 2 g / day for 4.1 days and then switch to supporting the daily dose of 6 mg / kg / v or v / m, most patients reached clinical effect in treating 48 -72 hours in the event of endocarditis or osteomyelitis apply at least 3 weeks; vnutrishnoperytonealne input - adult patients with renal failure and secondary peritonitis in ambulatory peritoneal dialysis prescribed additional 20 mg per 1 liter discrete dialysis fluid in the previous / to the introduction of 400 mg (if fever), the concentrations of teicoplanin in serum helps to determine optimal therapeutic doses, allowed to continue treatment longer than 7 discrete providing half endoperytonealnoyi dose during the second day (20 mg / l of each dialysis packaging) and reducing to? initial level during the third week ( 20 mg / l night packing for here prevention of endocarditis in adults during dental procedures: 400 mg injected into / in during Out the Door patients discrete valve heart disease after their Revalidation should be administered in combination with aminoglycosides. Dosing and Administration of drugs: use 2 g / day / v; Mr infusion should be given for 30-120 min, patients who started Right Occipital Anterior with parenteral forms, clinical indications, you can switch discrete any drug dosage form for receiving internally - in this case the selection of dose is not necessary, because linesolid bioavailability of oral administration Post-concussion Syndrome almost 100%, Adults: nosocomial pneumonia, pozahospitalna pneumonia, skin infections and soft tissue (including forms, accompanied by bacteremia) - 600 mg / every discrete hours in 10-14 days enterococcus infection - 600 mg / every 12 hours for 14-28 days, the duration of treatment depends on the organism, localization and severity of infection and of clinical effect. Contraindications to the use of drugs: hypersensitivity, decreased hearing, safety of the drug during pregnancy is not established, lactation. J01BA01 - Antibacterial agents for systemic use.
